Inventor · disambiguated record
Gustav Gaudernack
Also filed as: GAUDERNACK GUSTAV
21 granted patents·9 pending applications·402 citations·filing 1994–2022
96Inventor score
Top patents by PatentIndex Score
30 records- 0194US7794723B2Antigenic peptides derived from telomeraseGEMVAX AS·Filed 2006·Granted Sep 14, 2010·47 cites·8 claims
- 0290US6759046B1PeptidesGEMVAX AS·Filed 1999·Granted Jul 6, 2004·74 cites·9 claims
- 0389US8614177B2PeptidesGAUDERNACK GUSTAV·Filed 2011·Granted Dec 24, 2013·7 cites·9 claims
- 0489US8193326B2Nucleic acids encoding novel TERT polypeptidesGAUDERNACK GUSTAV·Filed 2008·Granted Jun 5, 2012·7 cites·2 claims
- 0589US7863244B2PeptidesGEMVAX AS·Filed 2006·Granted Jan 4, 2011·9 cites·15 claims
- 0688US7192927B2PeptidesGEMVAX AS·Filed 2004·Granted Mar 20, 2007·20 cites·12 claims
- 0785US7375117B2PolypeptidesGEMVAX AS·Filed 2006·Granted May 20, 2008·7 cites·13 claims
- 0885US7078416B2PolypeptidesGEMVAX AS·Filed 2001·Granted Jul 18, 2006·21 cites·30 claims
- 0984US5961978ATherapeutically useful peptides and peptide fragmentsNORSK HYDRO AS·Filed 1995·Granted Oct 5, 1999·62 cites·138 claims
- 1083US10383928B2Telomerase polypeptide vaccine for treating cancerULTIMOVACS AS·Filed 2017·Granted Aug 20, 2019·4 cites·30 claims
- 1183US9757439B2Peptide vaccine comprising mutant RAS peptide and chemotherapeutic agentTARGOVAX ASA·Filed 2015·Granted Sep 12, 2017·5 cites·18 claims
- 1277US2023277641A1Telomerase polypeptide vaccine for treating cancerULTIMOVACS ASA·Filed 2022·Application pending·0 cites
- 1376US9657068B2Telomerase polypeptide vaccine for treating cancerGAUDERNACK GUSTAV·Filed 2011·Granted May 23, 2017·3 cites·14 claims
- 1476US6861057B2Immunogenic β-amyloid peptideGEMVAX AS·Filed 1999·Granted Mar 1, 2005·36 cites·2 claims
- 1575US11998595B2Telomerase polypeptide vaccine for treating cancerULTIMOVACS AS·Filed 2019·Granted Jun 4, 2024·0 cites·15 claims
- 1673US11155786B2Universal killer T-cellUNIV OSLO HF·Filed 2016·Granted Oct 26, 2021·2 cites·16 claims
- 1770US12168045B2Vaccine in combination with an immune checkpoint inhibitor for use in treating cancerULTIMOVACS AS·Filed 2022·Granted Dec 17, 2024·0 cites·32 claims
- 1870US6090546AMethod for the detection of Ras oncogenes, in particular the K-ras oncogeneMEDINNOVA SF·Filed 1995·Granted Jul 18, 2000·44 cites·20 claims
- 1970US6090935AIsolation of nucleic acidMEDINNOVA SF·Filed 1994·Granted Jul 18, 2000·54 cites·24 claims
- 2065US11529403B2Telomerase polypeptide vaccine for treating cancerULTIMOVACS AS·Filed 2017·Granted Dec 20, 2022·0 cites·20 claims
- 2161US11419927B2Vaccine in combination with an immune checkpoint inhibitor for use in treating cancerULTIMOVACS AS·Filed 2017·Granted Aug 23, 2022·0 cites·20 claims
- 2261US2012269858A1PolypeptidesGAUDERNACK GUSTAV·Filed 2012·Application pending·0 cites
- 2359US2022127574A1Universal Killer T-CellUNIV OSLO HF·Filed 2021·Application pending·0 cites
- 2457US2020009238A1Engineered invariant chain molecule for improved mhc class i loadingUNIV OSLO·Filed 2019·Application pending·0 cites
- 2546US2025152688A1A ConjugateULTIMOVACS AB·Filed 2022·Application pending·0 cites
- 2645US12071467B2Specific binding molecules for hTERTUNIV OSLO HF·Filed 2019·Granted Aug 27, 2024·0 cites·14 claims
- 2744US2017106066A1Engineered invariant chain molecule for improved mhc class i loadingUNIV OSLO·Filed 2015·Application pending·0 cites
- 2836US2019358263A1Compositions and Methods for Cell TherapyUNIV OSLO HF·Filed 2017·Application pending·0 cites
- 2933US2019336529A1T-cell receptors which recognise frameshift mutants of tgfbriiUNIV OSLO HF·Filed 2017·Application pending·0 cites
- 3032US2004235175A1Method for transfection of rna using electrical pulsesFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gustav Gaudernack files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →